Prostaglandin deficiency promotes sensitization of adenylyl cyclase

Biological Chemistry

Volumn 381, Issue 5-6, 2000, Pages 525-529

  Weber, Stephan ^a,c   Lemoine, Horst ^b   Wasner, Heinrich K ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Adenylyl cyclase; Forskolin; Hypersensitivity; Prostaglandin E; Prostaglandylinositol cyclic phosphate

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; FLUORIDE; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON; INDOMETACIN; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SENSITIZATION;

ANIMALIA;

EID: 0033949163     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2000.068     Document Type: Article

References (27)

1. Bär, H.P., and Hechter, O. (1969). Adenylyl cyclase and hormone action. I. Effects of adrenocorticotropic hormone, glucagon and epinephrine on the plasma membrane of rat fat cells. Proc. Natl. Acad. Sci. USA 63, 350-356.
2. Bronstad, G.O., and Christoffersen, T. (1981). Inhibitory effect of prostaglandins on the stimulation by glucagon and adrenaline of formation of cyclic AMP in rat hepatocytes. Eur. J. Biochem. 117, 369-374.
3. Butcher, R.W., and Baird, C.E. (1968). Effects of prostaglandins on adenosine 3′,5′-monophosphate levels in fat and other tissues. J. Biol. Chem. 243, 1713-1717.
4. Gypakis, A., and Wasner, H.K. (1996). Biosynthesis of activated inositol phosphate, a novel class of inositol phosphates (abstract). Exp. Clin. Endocrinol. 104, A18.
5. Jacobowitz, O., and Iyengar, R. (1994). Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Natl. Acad. Sci. USA 91, 10630-10634.
6. Lai, H.L., Yang, T.H., Messing, R.O., Ching, Y.H., Lin, S.C., and Chern, Y. (1997). Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response. J. Biol. Chem. 272, 4970-4977.
7. Lemoine, H. (1992). β-Adrenoceptor ligands: characterization and quantification of drug effects. Quant. Struct. Act. Relat. 11, 211-218.
8. 1-and β2-adrenoceptor-mediated functions in feline heart. A β2-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 56-69.
9. Lemoine, H., and Overlack, C. (1992). Highly potent β2-sympathomimetics convert to less potent partial agonists as relaxants of guinea-pig tracheae maximally contracted by carbachol. Comparison of relaxation with receptor binding. J. Pharmacol. Exp. Ther. 261, 258-270.
10. Robertson, R.P. (1988). Eicosanoids as pluripotential modulators of pancreatic islet function. Diabetes 37, 367-370.
11. Salomon, Y., Londos, C., and Rodbell, M. (1974). A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
12. Sérusclat, P., Rosen, S.G., Smith, E.B., Shah, S.D., Clutter, W.E., and Cryer, P.E. (1983). Mononuclear leukocyte β2-adrenergic receptors and adenylate cyclase sensitivity in insulin-dependent diabetes mellitus. Diabetes 32, 825-829.
13. Shamon, H., Hendler, R., and Sherwin, R.S. (1980). Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetes. A mechanism for diabetic instability. Diabetes 29, 284-291.
14. 1 on human skeletal muscle with special regard to the amino acid metabolism. Vasa (Suppl.)28, 14-18.
15. Wasner, H.K. (1975). Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist. FEBS Lett. 57, 60-63.
16. Wasner, H.K. (1976). Preparation of a liver plasma membrane with an adrenalin-responsive adenylyl cyclase after inhibition of prostaglandin synthesis by indomethacin. FEBS Lett. 72, 127-130.
17. Wasner, H.K. (1981). Biosynthesis of cyclic AMP antagonist in hepatocytes from rats after adrenalin-or insulin-stimulation (isolation, purification and prostaglandin E requirement for its synthesis). FEBS Lett. 133, 260-264.
18. Wasner, H.K., and Salge, U. (1987). Prostaglandylinositol cyclic phosphate, an antagonist to cyclic AMP. Adv. in Prostaglandin, Thromboxane and Leukotriene Res. 17, 691-695.
19. Wasner, H.K., Lemoine, H., Junger, E., Leßmann, M., and Kaufmann, R. (1991). Prostaglandylinositol cyclic phosphate, a new second messenger. In: Prostaglandins, Leukotrienes, Lipoxins and PAF. J.M. Bailey, ed. (New York, USA: Plenum Press), pp. 153-168.
20. Wasner, H.K., Kaufmann, R., Lemoine, H. (1992). Mass spectrometric identification of prostaglandylinositol, the dephosphorylated cyclic AMP antagonist, cyclic PIP. Analusis 20, 171-177.
21. Wasner, H.K., Salge, U., and Gebel, M. (1993). The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate. Acta Diabetol. 30, 220-232.
22. Wasner, H.K., Weber, S., Partke, H.J., and Amini-Hadi-Kiashar, H. (1994). Indomethacin treatment causes loss of insulin action: involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol. 31, 175-182.
23. Wasner, H.K., Leßmann, M., Conrad, M., Amini, H., Psarakis, E., and Mir-Mohammad-Sadegh, A. (1996). Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes. Acta Diabetol. 33, 126-138.
24. Wasner, H.K., Salge, U., Psarakis, E., and Niktopoulos, A. (1997). Insulin resistance, a result of reduced synthesis of cyclic PIP, a mediator of insulin action? Regulation of cyclic PIP synthetase activity by oral antidiabetic and antihypertensive drugs. Acta Diabetol. 34, 257-264.
25. Wasner, H.K., Gebel, M., Hucken, S., Schaefer, M., and Kincses, M. (2000). Two different mechanisms for activation of cyclic PIP synthase: by a G protein or by protein tyrosine phosphorylation. Biol. Chem. 381, 145-153.
26. Whisnant, R.W., Gilman, A.G., and Dessauer, C.W. (1996). Interaction of the two cytosolic domains of mammalian adenylyl cyclase. Proc. Natl. Acad. Sci. USA 93, 6621-6625.
27. Zapf, J., Waldvogel, M., Zumstein, P., and Froesch, E.R. (1978). Increased sensitivity to epinephrine of the cyclic AMP-protein kinase system in adipose tissue of diabetic rats. FEBS Lett. 94, 43-46.